Xiaoli Cao
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 2%
- Enterobacteriaceae and Cronobacter Research
Papers in
-
- Antibiotic Resistance in Bacteria 37
-
- Circular RNAs in diseases 8
- Peroxisome Proliferator-Activated Receptors 6
- Co-authors
- Rui‐Xing Yin (29 shared papers)Wu‐Xian Chen (19 shared papers)Han Shen (22 shared papers)Dong‐Feng Wu (15 shared papers)Zhifeng Zhang (11 shared papers)Jin‐Zhen Wu (16 shared papers)Wanqing Zhou (19 shared papers)Lynn Htet Htet Aung (14 shared papers)
- Journals
- Lipids in Health and Disease (9 papers)Frontiers in Microbiology (8 papers)BMC Infectious Diseases (5 papers)International Journal of Molecular Sciences (3 papers)Annals of Clinical Microbiology and Antimicrobials (3 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Xiaoli Cao
130 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 128
- Molecular Medicine 500
- Endocrinology 221
- Applied Microbiology and Biotechnology 48
- Cancer Research 226
- Clinical Biochemistry 90
Countries citing papers authored by Xiaoli Cao
This map shows the geographic impact of Xiaoli Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Cao more than expected).
Fields of papers citing papers by Xiaoli Cao
This network shows the impact of papers produced by Xiaoli Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Cao. The network helps show where Xiaoli Cao may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoli Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 79 | |
| 2 | 2016 | 63 | |
| 3 | 2011 | 61 | |
| 4 | 2023 | 55 | |
| 5 | 2020 | 54 | |
| 6 | 2014 | 54 | |
| 7 | 2018 | 53 | |
| 8 | 2012 | 50 | |
| 9 | 2020 | 43 | |
| 10 | 2016 | 42 | |
| 11 | 2016 | 37 | |
| 12 | 2013 | 36 | |
| 13 | 2017 | 36 | |
| 14 | 2017 | 33 | |
| 15 | 2019 | 33 | |
| 16 | 2019 | 32 | |
| 17 | 2009 | 32 | |
| 18 | 2022 | 31 | |
| 19 | 2019 | 31 | |
| 20 | 2014 | 30 |
About Xiaoli Cao
Xiaoli Cao is a scholar working on Molecular Medicine, Molecular Biology, Cancer Research, Epidemiology and Surgery, having authored 141 papers that have together received 2.1k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (37 papers), Cancer-related molecular mechanisms research (9 papers), Circular RNAs in diseases (8 papers), MicroRNA in disease regulation (7 papers), Peroxisome Proliferator-Activated Receptors (6 papers), Lipoproteins and Cardiovascular Health (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). The work is most often cited by research in Molecular Medicine (500 citations), Endocrinology (221 citations), Applied Microbiology and Biotechnology (48 citations), Cancer Research (226 citations) and Clinical Biochemistry (90 citations). Xiaoli Cao has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Rui‐Xing Yin, Wu‐Xian Chen, Han Shen, Dong‐Feng Wu, Zhifeng Zhang, Jin‐Zhen Wu, Wanqing Zhou, Lynn Htet Htet Aung, Kui Zhang and Junhao Chen. Their work appears in journals such as Lipids in Health and Disease, Frontiers in Microbiology, BMC Infectious Diseases, International Journal of Molecular Sciences and Annals of Clinical Microbiology and Antimicrobials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.